Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update
THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of ...
EAACI-ESCD Skin Allergy Meeting (SAM) 2025: Pioneering Innovations in Skin Allergy and Contact Dermatitis
The Organising Committee is delighted to announce the seventh edition of the EAACI-ESCD Skin Allergy Meeting (SAM), Europe’s leading event dedicated to skin allergies. This year, SAM 2025 will take ...
Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring
SAN CARLOS, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Allakos Inc. (Company) (Nasdaq: ALLK), today announced topline results from its phase 1 clinical trial of AK006 in chronic spontaneous urticaria ...
Medscape21d
When Plants Attack: Diagnosing and Managing Phytodermatoses
Contact urticaria can be nonimmunological, as seen with nettles, which rapidly cause painful papules due to the release of histamine, acetylcholine, and 5-hydroxytryptophan. In some cases ...
FOX8 Cleveland22d
You actually can be allergic to the cold, local hospital says
The human body can actually have a physical reaction to the cold, it turns out. Cold urticaria is an allergic reaction that presents as hives, usually on the arms and legs, pediatric allergy and ...
The Sun28d
The six signs you could be allergic to the cold – and when your allergy could be life-threatening
Symptoms usually start minutes after coming into contact with something you're allergic ... The best way to treat cold urticaria is to avoid being cold. But the most common treatment is with ...
Healio29d
Patients with chronic spontaneous urticaria see well-controlled disease with briquilimab
100% of patients with a single 240 mg dose had complete response at week 8. Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab ...